BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7694694)

  • 1. Polymyositis-dermatomyositis and non-Hodgkin's lymphoma.
    Endo T; Kawaguchi N; Yashima M; Tei H; Hayakawa H
    Intern Med; 1993 Jun; 32(6):487-9. PubMed ID: 7694694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell lymphoma associated with eosinophilia.
    Watanabe K; Shinbo T; Kojima M; Naito M; Tanahashi N; Nara M
    Cancer; 1989 Oct; 64(8):1682-5. PubMed ID: 2477132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
    Konopka L; Pawelski S
    J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
    Shapiro CL; Yeap BY; Godleski J; Jochelson MS; Shipp MA; Skarin AT; Canellos GP
    Cancer; 1991 Aug; 68(4):699-705. PubMed ID: 1713121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring.
    Eifel PJ; McClure S
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):907-8. PubMed ID: 2476427
    [No Abstract]   [Full Text] [Related]  

  • 7. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
    Cuthbert RJ; Craig JI; Ludlam CA
    Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
    [No Abstract]   [Full Text] [Related]  

  • 8. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
    Martelli M; Gherlinzoni F; De Renzo A; Zinzani PL; De Vivo A; Cantonetti M; Falini B; Storti S; Meloni G; Rizzo M; Molinari AL; Lauria F; Moretti L; Lauta VM; Mazza P; Guardigni L; Pescarmona E; Pileri SA; Mandelli F; Tura S
    J Clin Oncol; 2003 Apr; 21(7):1255-62. PubMed ID: 12663712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: usefulness of local and regional irradiation and reduced dose chemotherapy.
    Oguchi M; Izuno I; Takei K; Shikama N; Sasaki S; Gomi K; Sone S
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):87-92. PubMed ID: 9054881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-hodgkins lymphoma.
    Mead G; Woodcock J; Young C
    Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of an aggressive non-Hodgkin's lymphoma during pregnancy with MACOP-B chemotherapy.
    Nantel S; Parboosingh J; Poon MC
    Med Pediatr Oncol; 1990; 18(2):143-5. PubMed ID: 1689451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO
    N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract]   [Full Text] [Related]  

  • 13. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
    J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage I non-Hodgkin's lymphoma treated with doxorubicin-containing chemotherapy with or without radiotherapy.
    Villikka K; Muhonen T; Ristamäki R; Teerenhovi L; Joensuu H
    Acta Oncol; 1997; 36(6):619-24. PubMed ID: 9408153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Longo DL; DeVita VT; Young RC
    N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
    [No Abstract]   [Full Text] [Related]  

  • 16. Oculomotor nerve palsy associated with vincristine treatment.
    Soysal T; Ferhanoğlu B; Bilir M; Akman N
    Acta Haematol; 1993; 90(4):209-10. PubMed ID: 7511314
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrathecal prophylaxis following autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Varadi G; Lossos A; Nagler A
    Acta Oncol; 1997; 36(3):349-50. PubMed ID: 9208912
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vibrio cholerae can be encountered even at home].
    Sinisalo M; Oksanen K; Koivisto V; Vikberg V
    Duodecim; 1991; 107(22):1880-3. PubMed ID: 1285425
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
    Pittrová H; Koza V; Vozobulová V; Cetkovský P; Skopek P; Jungerová J; Cepelák V
    Vnitr Lek; 1989 Dec; 35(12):1177-82. PubMed ID: 2483776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
    Pawelski S; Konopka L; Pakulska J; Gutkowska J
    Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.